Lumida
/MD
⌘K
Pediatrix Medical Group Inc

Pediatrix Medical Group Inc

MD
$26.77USD+0.15%+0.04 today

MARKET CAP

2.2B

P/E (TTM)

13.0x

FWD P/E

DAY RANGE

$27 – $27

52W RANGE

$16
$28

AI Summary

Stalk
StalkMedium

MD remains in a Stage 2 uptrend with higher highs & higher lows, trading in a tight range above the 9/20 EMA stack. The medium-term bias is firmly bullish based on structural continuation, but short-term timing is neutral. Stalk pullbacks into the 9/20 EMA zone for a higher-probability entry.

  • Q2 adjusted EBITDA $76M; revenue +4% YoY, 2% same-unit growth
  • Building tele-hybrid model, expanding telemedicine services nationwide
  • NICU days down 3% and same-unit volumes -2% signal patient decline
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.9B$2.0B$2.0B$2.0B$1.9B
YoY %+10.2%+3.2%+1.1%+0.9%-4.9%
P / Sales1.2x0.6x0.4x0.5x1.0x
EV / Sales2.0x1.4x1.0x1.1x1.5x
Gross Profit, Adj.$1.9B$2.0B$2.0B$2.0B$1.9B
YoY %+10.2%+3.2%+1.1%+0.9%-4.9%
Margin %100.0%100.0%100.0%100.0%100.0%
EV / Gross Profit2.0x1.4x1.0x1.1x1.5x
EBITDA, Adj.$249.9M$235.6M$194.0M$215.9M$252.9M
YoY %+24.7%-5.7%-17.7%+11.3%+17.1%
Margin %13.1%11.9%9.7%10.7%13.2%
EV / EBITDA15.0x11.5x10.7x10.4x11.2x
EBIT$195.6M$172.7M$7.3M$-59.0M$208.8M
YoY %+99.4%-11.7%-95.8%-906.1%+453.8%
Margin %10.2%8.8%0.4%-2.9%10.9%
EV / EBIT19.2x15.7x282.5x-38.1x13.6x
Net Income$131.0M$66.3M$-60.4M$-99.1M$165.4M
YoY %+116.4%-49.3%-191.1%-64.0%+266.9%
Net Margin6.9%3.4%-3.0%-4.9%8.6%
EPS (GAAP)$1.53$0.79-$0.73-$1.19$1.94
YoY %+116.0%-48.4%-192.4%-63.0%+263.0%